DMAMCL Induces Ferroptosis in Neuroblastoma, Targeting HMOX1 and STEAP3
DMAMCL induces ferroptosis in neuroblastoma by targeting HMOX1 in MYCN-amplified subtypes and STEAP3 in MYCN-nonamplified subtypes.
Therapeutic Area
Therapeutic area intelligence for Neuroblastoma with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.